Year in Review: Obesity
2023 highlights included new FDA approvals, more drugs in development, and a pivot away from BMI
Source: medpagetoday.com
Stay updated with breaking news from Surgery Still. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2023 highlights included new FDA approvals, more drugs in development, and a pivot away from BMI